← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Aggamin Pharmaceuticals, Llc
New York, NY
$3,068,041
Total funding
4
Grants
Funding over time
peak $849.9K · FY2013–18$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$3,068,041 · 4
By mechanism
R44$2,604,945 · 2
R43$463,096 · 2
Investigators at Aggamin Pharmaceuticals, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of a Novel Biologic to Treat Preeclampsia$849,886
R44 · FY2017 · HD
Novel ex-vivo Immunoadsorption Therapy to Treat Preeclampsia$623,844
R44 · FY2016 · HD
Novel ex-vivo Immunoadsorption Therapy to Treat Preeclampsia$619,246
R44 · FY2015 · HD
Development of a Novel Biologic to Treat Preeclampsia$511,969
R44 · FY2018 · HD
Novel ex-vivo Immunoadsorption Therapy to Treat Preeclampsia$245,087
R43 · FY2013 · HD
Development of a Novel Biologic to Treat Preeclampsia$218,009
R43 · FY2014 · HD